Breast cancer cells’ sugar craving is target for new type of treatment
The treatment exploits a novel link, identified by the scientists, between sugar processing in the cells and their growth and division. This approach to treating breast cancer offers a real alternative to chemotherapy as it targets the active cancer cells and not normal cells, reducing the risk of side effects that affect thousands of women undergoing treatment. Breast Cancer Campaign funded scientist, Dr Jeremy Blaydes at the University of Southampton, has shown for the first time that chemicals called cyclic peptide inhibitors can stop ‘sweet toothed’ cancer cells from growing and multiplying by blocking proteins in the cells called CtBPs (C-terminal binding proteins). …